Similar articles

• Oxypertine in schizophrenic psychoses. Controlled clinical trial in two psychiatric hospitals.

  Vinar O, Hamouz V, Bastecký J. Vinar O, et al. Act Nerv Super (Praha). 1968 Oct 3;10(3):315-7. Act Nerv Super (Praha). 1968. PMID: 4883240 Clinical Trial. No abstract available.
• The behavioral pharmacology of oxypertine.

  Claghorn J, Schoolar JC. Claghorn J, et al. J Clin Pharmacol J New Drugs. 1970 May-Jun;10(3):203-6. J Clin Pharmacol J New Drugs. 1970. PMID: 4910277 Clinical Trial. No abstract available.
• A comparative trial of oxypertine and chlorpromazine in the treatment of acute psychoses.

  Wadzisz FJ. Wadzisz FJ. Curr Ther Res Clin Exp. 1969 Dec;11(12):784-92. Curr Ther Res Clin Exp. 1969. PMID: 4984044 Clinical Trial. No abstract available.
• A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.

  Mishara AL, Goldberg TE. Mishara AL, et al. Biol Psychiatry. 2004 May 15;55(10):1013-22. doi: 10.1016/j.biopsych.2004.01.027. Biol Psychiatry. 2004. PMID: 15121486 Review.
• Studies on the effectiveness of antidepressant drugs.

  Smith A, Traganza E, Harrison G. Smith A, et al. Psychopharmacol Bull. 1969 Mar:Suppl:1-53. Psychopharmacol Bull. 1969. PMID: 4898337 Review. No abstract available.